Brokerages Expect Procter & Gamble (PG) Will Announce Quarterly Sales of $16.19 Billion

Equities analysts expect that Procter & Gamble (NYSE:PG) will post $16.19 billion in sales for the current quarter, according to Zacks. Eight analysts have provided estimates for Procter & Gamble’s earnings. The highest sales estimate is $16.43 billion and the lowest is $16.06 billion. Procter & Gamble reported sales of $15.61 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 3.7%. The firm is scheduled to issue its next earnings report before the market opens on Friday, April 20th.

On average, analysts expect that Procter & Gamble will report full-year sales of $66.95 billion for the current financial year, with estimates ranging from $66.63 billion to $67.24 billion. For the next fiscal year, analysts expect that the firm will report sales of $68.94 billion per share, with estimates ranging from $68.28 billion to $69.71 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Procter & Gamble.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, April 20th. The company reported $1.00 EPS for the quarter, missing the Zacks’ consensus estimate of $1.01 by ($0.01). Procter & Gamble had a net margin of 15.34% and a return on equity of 20.66%. The firm had revenue of $16.28 billion during the quarter, compared to analyst estimates of $16.22 billion. During the same quarter in the previous year, the business earned $0.96 EPS. Procter & Gamble’s revenue for the quarter was up 4.3% on a year-over-year basis.

PG has been the subject of a number of research reports. Zacks Investment Research upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $102.00 price target for the company in a research report on Monday, January 8th. Morgan Stanley reduced their price target on shares of Procter & Gamble from $92.00 to $85.00 and set an “equal weight” rating for the company in a research report on Thursday, April 5th. Goldman Sachs upgraded shares of Procter & Gamble from a “sell” rating to a “neutral” rating and set a $77.00 price target for the company in a research report on Tuesday, January 16th. Finally, Barclays set a $84.00 price target on shares of Procter & Gamble and gave the company a “hold” rating in a research report on Thursday, March 15th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Procter & Gamble currently has an average rating of “Hold” and a consensus target price of $84.85.

Shares of PG stock traded down $3.04 during midday trading on Monday, reaching $75.16. 10,625,456 shares of the company traded hands, compared to its average volume of 9,821,315. Procter & Gamble has a 1-year low of $74.20 and a 1-year high of $94.67. The company has a current ratio of 0.94, a quick ratio of 0.79 and a debt-to-equity ratio of 0.41. The company has a market cap of $197,722.34, a price-to-earnings ratio of 19.17, a PEG ratio of 2.48 and a beta of 0.57.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be given a dividend of $0.7172 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.69. This represents a $2.87 annualized dividend and a dividend yield of 3.82%. The ex-dividend date is Thursday, April 19th. Procter & Gamble’s payout ratio is currently 70.41%.

In other Procter & Gamble news, insider Deborah P. Majoras sold 4,591 shares of Procter & Gamble stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $87.48, for a total value of $401,620.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey K. Schomburger sold 37,776 shares of Procter & Gamble stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $81.37, for a total transaction of $3,073,833.12. The disclosure for this sale can be found here. Insiders have sold a total of 114,011 shares of company stock valued at $9,710,976 over the last 90 days. Insiders own 0.35% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the business. Signature Estate & Investment Advisors LLC purchased a new stake in shares of Procter & Gamble during the 4th quarter valued at $103,000. Earnest Partners LLC acquired a new position in shares of Procter & Gamble during the 4th quarter valued at $110,000. Harding Loevner LP acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at $119,000. Cerebellum GP LLC acquired a new position in shares of Procter & Gamble during the 4th quarter valued at $122,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in shares of Procter & Gamble during the 3rd quarter valued at $125,000. 60.95% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This story was first reported by WKRB News and is owned by of WKRB News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.wkrb13.com/2018/04/19/brokerages-expect-procter-gamble-pg-will-announce-quarterly-sales-of-16-19-billion.html.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in the United States, Canada, Puerto Rico, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company's Beauty segment offers hair care products, including conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirant and deodorant, personal cleansing, and skin care products.

Get a free copy of the Zacks research report on Procter & Gamble (PG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply